ICU Medical, Inc. (ICUI) vs Pulse Biosciences, Inc (PLSE)

ICU Medical, Inc. and Pulse Biosciences, Inc are both Medical Instruments & Supplies companies. ICU Medical, Inc. and Pulse Biosciences, Inc are of similar size ($4.2B and $3.9B). Pulse Biosciences, Inc has negative trailing earnings, so its P/E is not meaningful; ICU Medical, Inc. trades at 71.4×. Pulse Biosciences, Inc grew revenue faster over the last twelve months: 90.1% against −5.92%. ICU Medical, Inc. has the higher net margin (2.76% vs −5,609.4%) and the higher return on invested capital (2.27% vs −37.0%). Across the 18 metrics below, ICU Medical, Inc. leads on 13 and Pulse Biosciences, Inc on 5.

Valuation

Metric ICUI PLSE Medical Instruments & Supplies median
P/E 71.38 n/m 30.84
P/S 1.97 2,553.63 2.54
P/B 1.96 20.78 2.36
Price to free cash flow 21.87 n/m 23.46
EV/EBITDA 16.40 n/m 14.70
EV/Sales 2.36 2,573.09 2.78
Earnings yield 1.40% (2.28%) 0.25%
Free cash flow yield 4.57% (5.66%) 0.57%

Profitability

Metric ICUI PLSE Medical Instruments & Supplies median
Gross margin 40.27% 26.77% 53.46%
Operating margin 5.07% (5,821.08%) 2.26%
Net margin 2.76% (5,609.44%) 0.16%
Free cash flow margin 12.47% (14,462.52%) 4.10%
Return on equity 2.79% (60.67%) 0.00%
Return on assets 1.50% (54.01%) 0.00%
Return on invested capital 2.27% (37.01%) 0.13%

Growth

Metric ICUI PLSE Medical Instruments & Supplies median
Revenue growth (TTM) (5.92%) 90.08% 8.97%
EPS growth (last fiscal year) 100.62% (17.39%) 6.51%
Revenue growth, 5-year CAGR 11.91% — 8.85%
Net income growth, 5-year CAGR (61.53%) 0.00% 0.00%

Health

Metric ICUI PLSE Medical Instruments & Supplies median
Debt to equity 0.53 0.00 0.10
Current ratio 2.37 14.35 2.42
Net debt to EBITDA 3.91 1.06 0.97

Dividend

Metric ICUI PLSE Medical Instruments & Supplies median
Dividend yield — — 1.03%
Payout ratio — — 0.25

Size

Metric ICUI PLSE Medical Instruments & Supplies median
Market cap 4.19b 3.86b 1.64b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack